The government Thursday vowed to support Korean biopharma products in their efforts to expand overseas during a meeting with top executives of major firms.
In the meeting held to hear from industry’s concerns on research and development in biopharma products, Minister of Food and Drug Safety Sohn Mun-gi said he would seek ways to strengthen exports and support the manufacturing of Korean bio products developed by researchers.
 |
Minister of Food and Drug Safety Sohn Mun-gi (Yonhap) |
The meeting was attended by the CEOs of the top five firms including Samsung BioLogics, Celltrion, Sewon Cellontech, CJ HealthCare and SK Chemicals.
Before attending the meeting the minister visited the laboratory of Kolon Life Science in Guro-gu, Seoul, to speak with researchers who are working on developing gene therapies.
The ministry said in a statement that it planned to continue organizing on-site visits and other events to communicate with the biopharmaceutical community for the industry’s development
By Won Ho-jung (
hjwon@heraldcorp.com)
